{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:19:23Z","timestamp":1765887563511},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11033-013-2991-7","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T17:17:54Z","timestamp":1389115074000},"page":"1461-1468","source":"Crossref","is-referenced-by-count":5,"title":["Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt"],"prefix":"10.1007","volume":"41","author":[{"given":"Faten Zahran","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousry Mostafa","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Mohey","family":"El-Deen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa Sayed","family":"Sabea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"2991_CR1","first-page":"105","volume":"2","author":"S Jain","year":"2010","unstructured":"Jain S, Singhal S, Lee P, Xu R (2010) Molecular genetics of hepatocellular neoplasia. Am J Transl Res 2:105\u2013118","journal-title":"Am J Transl Res"},{"key":"2991_CR2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jso.21364","volume":"100","author":"S Padma","year":"2009","unstructured":"Padma S, Martinie JB, Iannitti DA (2009) Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 100:619\u2013634","journal-title":"J Surg Oncol"},{"key":"2991_CR3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3748\/wjg.v16.i4.418","volume":"16","author":"P Stefaniuk","year":"2010","unstructured":"Stefaniuk P, Cianciara J, Wiercinska-Drapalo A (2010) Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 16:418\u2013424","journal-title":"World J Gastroenterol"},{"key":"2991_CR4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/0003-4819-139-1-200307010-00012","volume":"139","author":"S Gupta","year":"2003","unstructured":"Gupta S, Bent S, Kohlwes J (2003) Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139:46\u201350","journal-title":"Ann Intern Med"},{"key":"2991_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1582-4934.2003.tb00222.x","volume":"7","author":"OC Trifan","year":"2003","unstructured":"Trifan OC, Hla T (2003) Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. Cell Mol Med 7:207\u2013222","journal-title":"Cell Mol Med"},{"key":"2991_CR6","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1007\/s000110050295","volume":"47","author":"MM Taketo","year":"1998","unstructured":"Taketo MM (1998) Cox-2 and colon cancer. Inflamm Res 47:S112\u2013S116","journal-title":"Inflamm Res"},{"key":"2991_CR7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11684-010-0021-x","volume":"4","author":"Liu Li-Feng","year":"2010","unstructured":"Li-Feng Liu, Jin-Liang Zhang, Qiong Chen, Ying Chang, Ju-Sheng Lin (2010) Cyclooxygenase-2 gene \u22121195G\/A genotype is associated with the risk of HBV-induced HCC: a case\u2013control study in Han Chinese people. Front Med China 4:90\u201395","journal-title":"Front Med China"},{"key":"2991_CR8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep.1840040516","volume":"4","author":"Y Deugnier","year":"1984","unstructured":"Deugnier Y (1984) Serum alpha l-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma. Hepatology 4:889\u2013892","journal-title":"Hepatology"},{"key":"2991_CR9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2169\/internalmedicine.38.927","volume":"38","author":"H Ishizuka","year":"1999","unstructured":"Ishizuka H, Nakayama T, Matsuoka S, Gotoh I, Ogawa M, Suzuki K, Tanaka N, Tsubaki K, Ohkubo H, Arakawa Y, Okana T (1999) Prediction of the development of hepatocellular carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-l-fucosidase activity. Intern Med 38:927\u2013931","journal-title":"Intern Med"},{"key":"2991_CR10","first-page":"277","volume":"13","author":"EE Motawa","year":"2001","unstructured":"Motawa EE, Mamdouh E, Awad MM, Mahmoud AA, Abdel Hakim SE, Tarek DH (2001) Serum alpha-l-fucosidase enzyme activity as a marker for hepatocellular carcinoma: comparison with AFP using ROC analysis. J Egypt Natl Cancer Inst 13:277\u2013283","journal-title":"J Egypt Natl Cancer Inst"},{"key":"2991_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000402029","volume":"26","author":"RB Herberman","year":"1979","unstructured":"Herberman RB (1979) Immunodiagnostics for cancer testing. A look at the future. Antibiot Chemother 26:38\u201344","journal-title":"Antibiot Chemother"},{"key":"2991_CR12","first-page":"164","volume":"79","author":"K Zielke","year":"1972","unstructured":"Zielke K, Okada S, O\u2019Brien J (1972) Fucosidosis: diagnosis by serum assay of alpha-l-fucosidase. J Lab Clin Med 79:164\u2013169","journal-title":"J Lab Clin Med"},{"key":"2991_CR13","volume-title":"SPSS programming and data management: a guide for SPSS and SAS users","author":"R Levesque","year":"2007","unstructured":"Levesque R (2007) SPSS programming and data management: a guide for SPSS and SAS users, 4th edn. SPSS Inc., Chicago","edition":"4"},{"key":"2991_CR14","first-page":"565","volume":"129","author":"X Zhang","year":"2005","unstructured":"Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129:565\u2013576","journal-title":"Gastroenterology"},{"key":"2991_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjc.6601906","volume":"91","author":"DG Cox","year":"2004","unstructured":"Cox DG, Pontes C, Guino E (2004) Polymorphisms in prostaglandin synthase2\/cyclooxygen2 (PTGS2\/Cox-2) and risk of colorectal cancer. Br J Cancer 91:339\u2013343","journal-title":"Br J Cancer"},{"key":"2991_CR16","first-page":"4005","volume":"5","author":"M Kondo","year":"1999","unstructured":"Kondo M, Yamamoto H, Nagano H, Okami J, Shimizu J, Eguchi H, Miyamoto A, Dono K, Umeshita K, Matsuura N, Wakasa K, Nakamori S, Sakon M, Monden M (1999) Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin Cancer Res 5:4005\u20134012","journal-title":"Clin Cancer Res"},{"key":"2991_CR17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/hep.510290355","volume":"29","author":"H Kogo","year":"1999","unstructured":"Kogo H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M (1999) Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29:688\u2013696","journal-title":"Hepatology"},{"key":"2991_CR18","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1096\/fj.01-0158fje","volume":"15","author":"M Casado","year":"2001","unstructured":"Casado M, Callejias NA, Rodrigo J, Zhao X, Dey SK, Bosca L, Martin-Sanz P (2001) Contribution of cyclooxygenase-2 to liver regeneration after partial hepatectomy. FASEB J 15:2016\u20132018","journal-title":"FASEB J"},{"key":"2991_CR19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0016-5085(03)00904-1","volume":"125","author":"H Yamamoto","year":"2003","unstructured":"Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, Chang-De J, Kobayashi S, Damdinsuren B, Dono k, Umeshia K, Sekimoto M, Sakon M, Matsuura N, Monden M (2003) JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis I. Gastroenterology 125:556\u2013571","journal-title":"Gastroenterology"},{"key":"2991_CR20","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/tx0155505","volume":"14","author":"TP Reilly","year":"2001","unstructured":"Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR (2001) A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 14:1620\u20131628","journal-title":"Chem Res Toxicol"},{"key":"2991_CR21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/gut.2003.038364","volume":"53","author":"O Nunez","year":"2004","unstructured":"Nunez O, Fernandez-Martinez A, Majano PL, Apolinario A, Gomez-Gonzalo M, Benedicto I, Lopez-Cabrera M, Bosca L, Clemente G, Garcia-Monzon C, Martin-Sanz P (2004) Increased itrahepatic cyclooxygenase-2, matrix metalloproteinase-2, and matrix metalloproteinase-9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53:1665\u20131672","journal-title":"Gut"},{"key":"2991_CR22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgh100","volume":"25","author":"RC Panguluri","year":"2004","unstructured":"Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W, Kittles RA (2004) Cox-2 gene promoor haplotypes and prostate cancer risk. Carcinogenesis 25:961\u2013966","journal-title":"Carcinogenesis"},{"key":"2991_CR23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15287390701289966","volume":"70","author":"J Gao","year":"2007","unstructured":"Gao J, Ke Q, Ma HX, Wang Y, Zhou Y, Hu ZB, Zhai XJ, Wang XC, Qing JW, Chen WS, Jin GF, Liu JY, Tan YF, Wang XR, Shen HB (2007) Functional polymorphism in the cyclooxygenase-2 (COX-2) gene and risk of breas cancer in a Chinese population. J Toxicol Environ Health A 70:908\u2013915","journal-title":"J Toxicol Environ Health A"},{"key":"2991_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1743-422X-7-375","volume":"31","author":"Y Nagao","year":"2010","unstructured":"Nagao Y, Sata M (2010) Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan. Virol J 31:375\u2013379","journal-title":"Virol J"},{"key":"2991_CR25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1523-1755.1999.00298.x","volume":"55","author":"D Fliser","year":"1999","unstructured":"Fliser D, Zurbruggen I, Mutschler E (1999) Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55:629\u2013634","journal-title":"Kidney Int"},{"issue":"23","key":"2991_CR26","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/01.CIR.0000042673.07632.76","volume":"106","author":"L Djousse","year":"2002","unstructured":"Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC (2002) Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 106(23):2919\u20132924","journal-title":"Circulation"},{"key":"2991_CR27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI102108","volume":"28","author":"WW Faloon","year":"1949","unstructured":"Faloon WW, Eckhardt RD, Murphy TL, Cooper AM, Davidson CS (1949) An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J Clin Investig 28:583\u2013594","journal-title":"J Clin Investig"},{"key":"2991_CR28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1530-0277.1983.tb05406.x","volume":"7","author":"MA Rothschild","year":"1983","unstructured":"Rothschild MA, Oratz M, Schreiber SS (1983) Effects of nutrition and alcohol on albumin synthesis. Alcohol Clin Exp Res 7:28\u201330","journal-title":"Alcohol Clin Exp Res"},{"key":"2991_CR29","volume-title":"Harper\u2019s biochemistry","author":"PA Mayes","year":"2000","unstructured":"Mayes PA (2000) Carbohydrate physiologic significance. In: Maurry RK, Grammer DK, Maye PA, Rodwell VW (eds) Harper\u2019s biochemistry, 25th edn. Appleton and Lange Librairie du liban, Beirut","edition":"25"},{"key":"2991_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/bjc.1989.84","volume":"59","author":"S Bukofzer","year":"1989","unstructured":"Bukofzer S (1989) Alpha-l-fucosidase as a marker of hepatocellular carcinoma. Br J Cancer 59:417\u2013420","journal-title":"Br J Cancer"},{"key":"2991_CR31","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2468::AID-CNCR9>3.0.CO;2-Y","volume":"83","author":"MG Giardina","year":"1998","unstructured":"Giardina MG, Matarazzo M, Morante R, Lucariello A, Varriale A, Guardasole V, De Marco G (1998) Serum alpha-l-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis. Cancer 83:2468\u20132474","journal-title":"Cancer"},{"key":"2991_CR32","first-page":"110","volume":"30","author":"P Tangkijvanich","year":"1999","unstructured":"Tangkijvanich P, Tosukhowong P, Bunyongyod P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, Poovorawan Y (1999) Alpha-l-fucosidase as a marker of hepatocellular carcinoma in Thailand. Southeast Asian J Trop Med Public Health 30:110\u2013114","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2991_CR33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/gast.2002.33411","volume":"122","author":"AS Befeler","year":"2002","unstructured":"Befeler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122:1609\u20131619","journal-title":"Gastroenterology"},{"key":"2991_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1089-3261(05)70156-2","volume":"5","author":"M Colombo","year":"2001","unstructured":"Colombo M (2001) Screening for cancer in viral hepatitis. Clin Liver Dis 5:109\u2013122","journal-title":"Clin Liver Dis"},{"key":"2991_CR35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13651820410024049","volume":"7","author":"ES Bialecki","year":"2005","unstructured":"Bialecki ES, Di Bisceglie AM (2005) Diagnosis of hepatocellular carcinoma. HPB (Oxford) 7:26\u201334","journal-title":"HPB (Oxford)"},{"key":"2991_CR36","first-page":"420","volume":"8","author":"S Kreczko","year":"2000","unstructured":"Kreczko S, Lipska A, Wysocka J (2000) Alpha-fetoprotein: diagnostic value in hepatic disorders. Pol Merkur Lekarski 8:420\u2013423","journal-title":"Pol Merkur Lekarski"},{"key":"2991_CR37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.bjc.6600016","volume":"86","author":"DC Mou","year":"2002","unstructured":"Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, Leng XS, Chen WF (2002) Evaluation of MAGE-1 and MAGE-3 as tumor-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86:110\u2013116","journal-title":"Br J Cancer"},{"key":"2991_CR38","first-page":"487","volume":"36","author":"J Peng","year":"2002","unstructured":"Peng J, Cai S, Leng X, Mu D, Lu J, Chen H, Rui J (2002) mRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 36:487\u2013490","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"2991_CR39","first-page":"83","volume":"11","author":"MA Ali","year":"2004","unstructured":"Ali MA, Koura BA, El-Mashad N, Zaghloul MH (2004) The Bcl-2 and TGF-betal levels in patients with chronic hepatitis C, liver cirrhosis and HCC. Egypt J Immunol 11:83\u201390","journal-title":"Egypt J Immunol"},{"key":"2991_CR40","first-page":"50","volume":"4","author":"YM He","year":"2005","unstructured":"He YM, Wang XY, Gao SD, Yu LY, Lin XD, Lin LW (2005) Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 4:50\u201354","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2991_CR41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","volume":"43","author":"AM Bisceglie Di","year":"2005","unstructured":"Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR (2005) Serum AFP levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol 43:434\u2013441","journal-title":"J Hepatol"},{"key":"2991_CR42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004836-200103000-00014","volume":"32","author":"CW Chu","year":"2001","unstructured":"Chu CW, Hwang SJ, Luo JC, Lai CR, Tsay SH, Li CP, Wu JC, Chang FY, Lee SD (2001) Clinical, virology, and pathologic significance of elevated serum AFP levels in patients with chronic hepatitis C. J Clin Gastroenterol 32:240\u2013244","journal-title":"J Clin Gastroenterol"},{"key":"2991_CR43","first-page":"1471","volume":"28","author":"O Arrieta","year":"2007","unstructured":"Arrieta O, Cacho B, Morales-Espinosa D, Ruelas-villavicencio A, Flores-Estrada D, Hernandez-Pedro N (2007) The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer 28:1471\u20132407","journal-title":"BMC Cancer"},{"key":"2991_CR44","first-page":"57","volume":"42","author":"JA Nikolic","year":"1992","unstructured":"Nikolic JA (1992) Synthesis, structure and function of alpha-fetoproteins and their importance in medicine. Glas Srp Akad Nauka Med 42:57\u201373","journal-title":"Glas Srp Akad Nauka Med"},{"key":"2991_CR45","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejso.2007.02.036","volume":"33","author":"GG Chen","year":"2007","unstructured":"Chen GG, Ho RLK, Wong J, Lee KF, Lai PBS (2007) Single nucleotide polymorphism in the promotor region of human an alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC). Eur J Surg Oncol (EJSO) 33:882\u2013886","journal-title":"Eur J Surg Oncol (EJSO)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2991-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T23:16:56Z","timestamp":1565047016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,8]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2991"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2991-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,8]]}}}